Nigel Davies
Overview
Explore the profile of Nigel Davies including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sassani M, Mitchell J, Yiangou A, Davies N, Sawlani V, Mollan S, et al.
Eye (Lond)
. 2025 Jan;
PMID: 39856425
Background/objectives: Idiopathic intracranial hypertension (IIH) is a disease which threatens vision and causes disabling headaches, affecting women of childbearing age with obesity. It is characterised by raised intracranial pressure (ICP),...
2.
Maguire M, Laidlaw D, Davies N, Hammond C
Graefes Arch Clin Exp Ophthalmol
. 2024 May;
262(11):3501-3508.
PMID: 38771336
Background: The influence of Vitreomacular Interface Abnormalities (VMIA) such as Epiretinal Membrane (ERM) and/or vitreomacular traction (VMT) on the response of patients with Centre Involving Diabetic Macular Edema (CIDME) to...
3.
Tejedor S, Wagberg M, Correia C, Avall K, Holtta M, Hultin L, et al.
Cells
. 2024 Mar;
13(5.
PMID: 38474378
Background: Diabetic foot ulcers (DFU) pose a significant health risk in diabetic patients, with insufficient revascularization during wound healing being the primary cause. This study aimed to assess microvessel sprouting...
4.
Gallagher K, Brown F, Bilal A, Al-Janabi A, Davies N
Eye (Lond)
. 2024 Mar;
38(9):1614-1615.
PMID: 38438794
No abstract available.
5.
Kohe S, Bennett C, Burte F, Adiamah M, Rose H, Worthington L, et al.
EBioMedicine
. 2024 Jan;
100:104958.
PMID: 38184938
Background: The malignant childhood brain tumour, medulloblastoma, is classified clinically into molecular groups which guide therapy. DNA-methylation profiling is the current classification 'gold-standard', typically delivered 3-4 weeks post-surgery. Pre-surgery non-invasive...
6.
McGowan A, Gennemark P, Akieh-Pirkanniemi M, Wirman L, Davies N, Elebring M, et al.
Mol Pharm
. 2023 Dec;
21(1):143-151.
PMID: 38126776
Single-stranded antisense oligonucleotides (ASOs) are typically administered subcutaneously once per week or monthly. Less frequent dosing would have strong potential to improve patient convenience and increase adherence and thereby for...
7.
Emeh P, Breitholtz K, Berg S, Vedin C, Englund M, Uggla T, et al.
Mol Pharm
. 2023 Dec;
21(1):313-324.
PMID: 38054599
Transient permeation enhancers (PEs) have been widely used to improve the oral absorption of macromolecules. During pharmaceutical development, the correct selection of the macromolecule, PE, and the combination needs to...
8.
Leamy M, Sims S, Levenson R, Davies N, Brearley S, Gourlay S, et al.
BMC Health Serv Res
. 2023 Dec;
23(1):1341.
PMID: 38042788
Background: In response to concerns about high hospital mortality rates, patient and carer complaints, a Mid Staffordshire NHS Foundation Trust public inquiry was conducted at the request of the UK...
9.
Isba R, Brennan L, Egboko F, Edge R, Davies N, Knight J
BMJ Open
. 2023 Jun;
13(6):e072053.
PMID: 37369415
Objective: To estimate vaccination coverage among children under the age of five attending the paediatric emergency department (PED) using tetanus and MMR vaccination as a proxy. Design: A cross-sectional observational...
10.
Gallagher K, Al-Janabi A, Davies N
Eye (Lond)
. 2023 Apr;
37(16):3511-3512.
PMID: 37055563
No abstract available.